Rhie, Jeong Yeon Professor
Pharmaceutical Sciences/Industrial Pharmaceutical Science/Division of Pharmacy
Dr. Sandy (Jeong Yeon) Rhie is an associate professor in College of Pharmacy and act as a pharmacy departement chair in Ewha Graduate School of Clinical Health Sciences. She received her PhD degree from Ewha Womans University and PharmD degree from the University of Maryland at Baltimore. She is appointed as clinical assistant professor at University of Maryland School of Pharmacy and an adjunct experiential faculty at Albany College of Pharmacy and Health Scences. She completed a pharmacy practice residency at Mercy Suburban Hospital in Philadelphia. Until she joined the faculty in Ewha at 2012, she has worked at the Hospital of University of Pennsylvania as an inpatient anticoagulation pharmacy specialist. She served as a preceptor to pharmacy students and residents and provided inpatient care of anticoagulation management services, and involved in the preparation of policy and procedure at Hospital of the University of Pennsylvania. Her research interests include factors that influence the variability of anticoagulation drugs, the safe use of direct thrombin inhibitors. With target-specific oral anticoagulants available, she works to assure provision of safe, effective and cost-effective antithrombotic therapy to patient care. She also involves in developing pharmaceutical care model in cardiovascular disease patients. She published related research finding and presented in several conferences. She also participated in publish Pharmacotherapy 3ed, Drug information 4th ed, Applied therapeutics:the clinical use of drugs, Introductory pharmacy experiential education in Korean as an author. She has Ewha Womans Hospital as her practice site and implement impatient anticoagulation pharmacy service and also initiated physician collaborated student rotation program. Not only her medication-related research, but she also focuses on pharmacy students education to grow as health care professionals to understand the current issues and the responsibilities.
- Division Chair, Life & Pharmaceutical Sciences
- Pharmaceutical Science Building A(Appenzeller Hall) #304
- 02-3277-3023
Research Record
- Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis Scientific Reports, 2023, v.13 no.1, 5727
- Institutional-specific smartphone application as a supplemental tool for an antimicrobial stewardship program in 2 large community-based hospitals: Acceptance of physicians and pharmacists JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, v.63 no.3, 0
- Novel innovative computer-based test (Inno-CBT) item types for national licensing examinations for health care professionals BMC Medical Education, 2023, v.23 no.1, 560
- Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia Journal of Critical Care, 2023, v.78, 154402
- Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study International Journal of Antimicrobial Agents, 2023, v.62 no.5, 106966
- Long-Term Survival and Kidney Function in Pediatric Patients Following Liver Transplantation: A 15-Year Retrospective Cohort Study CHILDREN-BASEL, 2022, v.9 no.10, 1544
- Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT Journal of Critical Care, 2022, v.72, 154172
- Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, v.19 no.15, 9196
- Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis HEALTHCARE, 2022, v.10 no.2, 217
- Broad-spectrum antibiotic regimen affects survival in patients receiving nivolumab for non-small cell lung cancer Pharmaceuticals, 2021, v.14 no.5, 445
- Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy PHARMACEUTICALS, 2021, v.14 no.11, 1200
- P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis JOURNAL OF PERSONALIZED MEDICINE, 2021, v.11 no.3, 222
- Quantification of teicoplanin using the hplc-uv method for clinical applications in critically ill patients in Korea Pharmaceutics, 2021, v.13 no.4, 572
- Signal detection of adverse drug reactions of cephalosporins using data from a national pharmacovigilance database Pharmaceuticals, 2021, v.14 no.5, 425
- Validation of a questionnaire for patient awareness and the need for a community-based outpatient antimicrobial stewardship program (O-asp): A pilot study Antibiotics, 2021, v.10 no.4, 441
- 스포츠 약학: 새로운 영역의 약사 역할과 전문 약료서비스 준비 한국임상약학회지, 2021, v.31 no.1, 12-20
- Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment AMERICAN JOURNAL OF SURGERY, 2020, v.219 no.6, 963-968
- Effect of post-operative anticoagulation management in patients who have undergone On-X mechanical heart valve replacement surgery on post-discharge warfarin therapy Journal of Clinical Pharmacy and Therapeutics, 2020, v.45 no.4, 767-773
- Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis Scientific Reports, 2020, v.10 no.1, 530
- Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, v.45 no.5, 1199-1205
- Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition at a Community-based Hospital 한국임상약학회지, 2020, v.30 no.2, 120-126
- 급성 이식편대숙주병 예방을 위한 Tacrolimus 적정 혈중농도 설정 병원약사회지, 2020, v.37 no.4, 444-458
- Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis ANTIBIOTICS-BASEL, 2019, v.8 no.4, 252
- Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients PHARMACEUTICS, 2019, v.11 no.6
- Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, v.28 no.4, 507-514
- Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients Scientific Reports, 2019, v.9 no.1, 8781
- Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics PHARMACEUTICS, 2019, v.11 no.1, 23
- Factors related to inappropriate edoxaban use Journal of Clinical Pharmacy and Therapeutics, 2019, v.44 no.5, 760-767
- Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, v.41 no.2, 424-433
- Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, v.36 no.7, 616-622
- Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study Journal of Clinical Pharmacy and Therapeutics, 2019, v.44 no.1, 84-90
- Pharmacokinetic alteration of paclitaxel by ferulic acid derivative Pharmaceutics, 2019, v.11 no.11, 593
- Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games BRITISH JOURNAL OF SPORTS MEDICINE, 2019, v.53 no.17, 1105-1110
- Prescribing patterns of polypharmacy in Korean pediatric patients PLOS ONE, 2019, v.14 no.10, e0222781
- PyeongChang 2018 Winter Olympic Games and athletes' usage of a € polyclinic' medical services BMJ Open Sport and Exercise Medicine, 2019, v.5 no.1, e000548
- The influence of a patient counseling training session on pharmacy students' self-perceived communication skills, confidence levels, and attitudes about communication skills training BMC MEDICAL EDUCATION, 2019, v.19, 172
- Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, v.30 no.10, 1177-1185
- Development and clinical application of an evidence-based pharmaceutical care service algorithm in acute coronary syndrome Journal of Clinical Pharmacy and Therapeutics, 2018, v.43 no.3, 366-376
- Dose Optimization Based on Population Pharmacokinetic Modeling of High-Dose Cyclosporine, a P-glycoprotein Inhibitor, in Combination with Systemic Chemotherapy in Pediatric Patients with Retinoblastoma JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, v.34 no.9, 647-655
- Effects of Concomitant Medication Use on Gefitinib-Induced Hepatotoxicity JOURNAL OF CLINICAL PHARMACOLOGY, 2018, v.58 no.2, 263-268
- Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity Anti-Cancer Drugs, 2018, v.29 no.5, 471-476
- Laparoscopic Cholecystectomy 수술 후 Sugammadex와 Neostigmine 간에 첫 자발호흡과 부작용 발현 연구 한국임상약학회지, 2018, v.28 no.2, 101~106
- Nutrition and Clinical Outcomes of Nutrition Support in Multidisciplinary Team for Critically Ill Patients NUTRITION IN CLINICAL PRACTICE, 2018, v.33 no.5, 633-639
- Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2018, v.25 no.1, 21-25
- Service design oriented multidisciplinary collaborative team care service model development for resolving drug related problems PLOS ONE, 2018, v.13 no.9, e0201705
- 급성전골수구성백혈병 환자에서 all-trans retinoic acid (ATRA)의 분화증후군 발생과 위험인자 분석 병원약사회지, 2018, v.35 no.1, 39~47
- 노인층에서 Clostridium difficile 감염 약물사용평가 및 비호전군에 대한 영향인자 한국임상약학회지, 2018, v.28 no.3, 174~180
- 상급종합병원 암센터에서 Nivolumab 사용평가와 치료성과에 미치는 영향인자 한국임상약학회지, 2018, v.28 no.2, 88~94
- 수술 후 자가통증조절장치 사용 환자에서 propacetamol과 fentanyl 복합제 및 fentanyl 단일제제의 효과 비교 한국임상약학회지, 2018, v.28 no.1, 17~23
- 응급의료센터 자동약품분배 캐비닛시스템 운영으로 인한 야간 약국업무개선 한국임상약학회지, 2018, v.28 no.1, 51~56
- Changes in cognitive function and brain glucose metabolism in elderly women with subjective memory impairment: a 24-month prospective pilot study Acta Neurologica Scandinavica, 2017, v.135 no.1, 108-114
- Diagnostic potential of multimodal neuroimaging in posttraumatic stress disorder PLOS ONE, 2017, v.12 no.5, e0177847
- Effects of Adamantyl Derivatives on Pharmacokinetic Behavior of Paclitaxel in Rats BIOMOLECULES & THERAPEUTICS, 2017, v.25 no.5, 553-558
- Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients Medical Oncology, 2017, v.34 no.12, 199
- Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea PATIENT PREFERENCE AND ADHERENCE, 2017, v.11, 1381-1388
- The effect of communication skills training on patient-pharmacist communication in pharmacy education: a meta-analysis Advances in Health Sciences Education, 2017, v.23 no.3, 1-20
- 알츠하이머병 및 건망증 경도 인지장애의 인슐린 비강투여: 체계적 문헌 고찰 및 메타분석 한국임상약학회지, 2017, v.27 no.3, 161~170
- Effects of Ganglioside on Working Memory and the Default Mode Network in Individuals with Subjective Cognitive Impairment: A Randomized Controlled Trial AMERICAN JOURNAL OF CHINESE MEDICINE, 2016, v.44 no.3, 489-514
- Factors affecting medication adherence in elderly people PATIENT PREFERENCE AND ADHERENCE, 2016, v.10, 2117-2125
- Molecular Neuroimaging in Posttraumatic Stress Disorder Experimental Neurobiology, 2016, v.25 no.6, 277
- Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report MEDICINE, 2016, v.95 no.21
- Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: a qualitative study INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, v.38 no.5, 1219-1229
- Pharmacist-involved care for patients with heart failure and acute coronary syndrome: A systematic review with qualitative and quantitative meta-analysis Journal of Clinical Pharmacy and Therapeutics, 2016, 7 MAR 2016
- 비고령 성인환자의 만성폐쇄성폐질환 약물사용 현황과 영향인자 한국임상약학회지, 2016, v.26 no.4, 298
- 비판막성 심방세동 환자의 뇌졸중 예방에서 dabigatran과 rivaroxaban의임상적용의 현황 한국임상약학회지, 2016, v.26 no.3, 207~212
- 상급종합병원과 희귀난치성질환 전문병원의 희귀의약품 사용현황 한국임상약학회지, 2016, v.26 no.3, 267~267
- 중환자에서 스트레스성 궤양 예방 약물에 따른 감염성 합병증 발생률 비교 한국임상약학회지, 2016, v.26 no.1, 46-52
- 내과계 중환자실 약료 서비스 도입과 약물상호작용 모니터링 한국임상약학회지, 2015, v.25 no.3, 138-144
- 상급종합병원 근처의 한 지역약국 처방전 분석에 의한 노인 환자의 다약제복용과 약제비용 및 잠재적으로 부적절한 약물사용 관련 위험인자 한국임상약학회지, 2015, v.25 no.3, 159-165
- 지역약국 필수실무실습에 관한 프리셉터와 학생의 인식 비교 한국임상약학회지, 2015, v.25 no.2, 102-110
- Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, v.723, 381-388
- Effects of inflammatory cytokine gene polymorphisms on warfarin maintenance doses in Korean patients with mechanical cardiac valves ARCHIVES OF PHARMACAL RESEARCH, 2014, v.37 no.6, 752-759
- Pharmacokinetic evaluation of formulated levodopa methyl ester nasal delivery systems EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2014, v.39 no.4, 237-242
- 고관절치환술 후의 Rivaroxaban의 국내임상적용 한국임상약학회지, 2014, 제24권 1호, 1-8
- 복막투석 환자의 빈혈 관리에 있어 에리스로포이에틴 자극제의 사용현황 및 비교평가 한국임상약학회지, 2014, 제24권 3호, 206-212
- [학술지논문] Novel innovative computer-based test (Inno-CBT) item types for national licensing examinations for health care professionals BMC MEDICAL EDUCATION, 2023, v.23 no.1 , 560-566
- [학술지논문] Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia JOURNAL OF CRITICAL CARE, 2023, v.78 no.0 , 154402-154402
- [학술지논문] Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment AMERICAN JOURNAL OF SURGERY, 2020, v.219 no.6 , 963-968
- [학술지논문] Effect of post-operative anticoagulation management in patients who have undergone On-X mechanical heart valve replacement surgery on post-discharge warfarin therapy JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, v.45 no.4 , 767-773
- [학술지논문] Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, v.45 no.5 , 1199-1205
- [학술지논문] Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis Antibiotics, 2019, v.8 no.4 , 252-252
- [학술지논문] Application of size and maturation functions to population pharmacokinetic modeling of pediatric patients PHARMACEUTICS, 2019, v.11 no.6 , 0-0
- [학술지논문] Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, v.28 no.4 , 507-514
- [학술지논문] Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically III Patients SCIENTIFIC REPORTS, 2019, v.9 no.0 , 8781-8781
- [학술지논문] Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics PHARMACEUTICS, 2019, v.11 no.1 , 23-23
- [학술지논문] Factors related to inappropriate edoxaban use JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, v.44 no.5 , 760-767
- [학술지논문] Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, v.41 no.2 , 424-433
- [학술지논문] Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, v.36 no.7 , 616-622
- [학술지논문] Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, v.44 no.1 , 84-90
- [학술지논문] Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative PHARMACEUTICS, 2019, v.11 no.11 , 593-593
- [학술지논문] Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games BRITISH JOURNAL OF SPORTS MEDICINE, 2019, v.53 no.17 , 1105-1110
- [학술지논문] Prescribing patterns of polypharmacy in Korean pediatric patients PLOS ONE, 2019, v.14 no.10 , 0222781-0222781
- [학술지논문] PyeongChang 2018 Winter Olympic Games and athletes’ usage of ‘polyclinic’ medical services BMJ Open Sport & Exercise Medicine, 2019, v.5 no.1 , 548-548
- [학술지논문] The influence of a patient counseling training session on pharmacy students' self-perceived communication skills, confidence levels, and attitudes about communication skills training BMC MEDICAL EDUCATION, 2019, v.19 no.0 , 172-172
- [학술발표] Antibiotics treatment pathways and prescribing preferences in treating patients with clinically suspected hospital-acquired pneumonia using cohort pathway applications 2020 European OHDSI Symposium, 영국, 2020-06-23 OHDSI, 2020
Courses
-
2024-1st
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 01
- 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 3~3 (POSCO551)
- Major Requisite
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 02
- 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A404) , Wed 5~5 (PHM-)
- Major Requisite
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 03
- 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Wed 2~2 (POSCO551)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 03
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 04
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 05
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 06
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Introduction to Pharmaceutical Research
- Subject No 38940Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A404)
- Major Requisite
-
Clinical Data Analysis and Applications 강의 계획서 상세보기
- Subject No G18092Class No 01
- Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
-
Pharmacotherapy in Cardiovascular & Respiratory Disorders
- Subject No AP531Class No 01
- Year ( 3Credit , 3Hour)
-
Pharmaceutical care in sports and doping prevention
- Subject No AP651Class No 01
- Year ( 3Credit , 3Hour)
-
Pharmacotherapy in Cardiovascular & Respiratory Disorders 강의 계획서 상세보기
- Subject No CP531Class No 01
- Year ( 3Credit , 3Hour) Mon 8~9 (POSCO-451)
-
-
2023-2nd
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 01
- 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A100-1) , Thu 6~6 (POSCO552)
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 02
- 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A100-1) , Wed 3~3 (POSCO552)
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 03
- 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A100-1) , Thu 4~4 (POSCO462)
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 04
- 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A100-1) , Thu 4~4 (POSCO462)
- Major Requisite
-
Advanced Pharmacy Practice and Research I 강의 계획서 상세보기
- Subject No 37154Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅱ 강의 계획서 상세보기
- Subject No 37155Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅲ 강의 계획서 상세보기
- Subject No 37156Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Pharmacotherapy in Neuro-Psychiatric Disorders
- Subject No AP524Class No 01
- Year ( 3Credit , 3Hour)
-
Pharmacotherapy in Neuro-Psychiatric Disorders
- Subject No CP524Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (POSCO-451)
-
-
2023-1st
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 01
- 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Wed 5~5 (PHM-)
- Major Requisite
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 02
- 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 3~3 (PHM-A404)
- Major Requisite
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 03
- 5Year ( 3Credit , 3Hour) Mon 2~2 (PHM-A404) , Wed 2~2 (PHM-A404)
- Major Requisite
-
Pharmacotherapeutics Ⅲ 강의 계획서 상세보기
- Subject No 37136Class No 04
- 5Year ( 3Credit , 3Hour) Mon 2~2 (PHM-A404) , Wed 2~2 (PHM-A404)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Thu 6~9 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 04
- 5Year ( 1.5Credit , 3Hour) Thu 6~9 (PHM-A206)
- Major Requisite
-
Hospital Pharmacy Practice I 강의 계획서 상세보기
- Subject No 37150Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I 강의 계획서 상세보기
- Subject No 37150Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I 강의 계획서 상세보기
- Subject No 37150Class No 03
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I 강의 계획서 상세보기
- Subject No 37150Class No 04
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I 강의 계획서 상세보기
- Subject No 37150Class No 05
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I 강의 계획서 상세보기
- Subject No 37150Class No 06
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Introduction to Pharmaceutical Research 강의 계획서 상세보기
- Subject No 39045Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-)
-
Clinical Data Analysis and Applications 강의 계획서 상세보기
- Subject No G18092Class No 01
- Year ( 3Credit , 3Hour) Tue 4~5 (PHM-)
-
Pharmacotherapy in bone and joint disorders, and geriatrics 강의 계획서 상세보기
- Subject No CP649Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
-
-
2022-2nd
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
- Major Requisite
-
Pharmacotherapeutics Ⅴ 강의 계획서 상세보기
- Subject No 37145Class No 01
- 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A104) , Wed 4~4 (POSCO362)
- Major Requisite
-
Pharmacotherapeutics Ⅴ 강의 계획서 상세보기
- Subject No 37145Class No 02
- 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A104) , Thu 5~5 (POSCO359)
- Major Requisite
-
Pharmacotherapeutics Ⅴ 강의 계획서 상세보기
- Subject No 37145Class No 03
- 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A104) , Wed 5~5 (POSCO)
- Major Requisite
-
Pharmacotherapeutics Ⅴ 강의 계획서 상세보기
- Subject No 37145Class No 04
- 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A104) , Wed 5~5 (POSCO)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅱ
- Subject No 37155Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Pharmacotherapy in infectious, dermatologic, and gynecologic and obstetric disorders 강의 계획서 상세보기
- Subject No CP546Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
-
-
2022-1st
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 01
- 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A404) , Wed 3~3 (POSCO152)
- Major Requisite
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 02
- 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Wed 4~4 (POSCO152)
- Major Requisite
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 03
- 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 2~2 (POSCO152)
- Major Requisite
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 04
- 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 2~2 (POSCO152)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Thu 6~7 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 04
- 5Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A206)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 01
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 03
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 04
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 05
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Clinical Data Analysis and Applications
- Subject No G18092Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (-)
-
Pharmacotherapy in Cardiovascular & Respiratory Disorders
- Subject No CP531Class No 01
- Year ( 3Credit , 3Hour) Mon 8~9 (ECC-)
-
-
2021-2nd
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 01
- 5Year ( 3Credit , 3Hour) Mon 4~4 , Wed 5~5
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 02
- 5Year ( 3Credit , 3Hour) Tue 4~4 , Thu 5~5
- Major Requisite
-
Pharmacotherapeutics Ⅴ
- Subject No 37145Class No 03
- 5Year ( 3Credit , 3Hour) Mon 5~5 , Wed 4~4
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅲ
- Subject No 37156Class No 02
- 6Year ( 4Credit
- Major Requisite
-
Pharmacotherapy in Neuro-Psychiatric Disorders
- Subject No CP524Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
-
Pharmacotherapy in Neuro-Psychiatric Disorders
- Subject No CP524Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
-
Pharmacotherapy in Neuro-Psychiatric Disorders
- Subject No CP524Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
-
Pharmacotherapy in Neuro-Psychiatric Disorders
- Subject No CP524Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
-
-
2021-1st
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 01
- 5Year ( 3Credit , 3Hour) Tue 5~5 , Thu 3~3
- Major Requisite
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 02
- 5Year ( 3Credit , 3Hour) Tue 7~7 , Thu 4~4
- Major Requisite
-
Pharmacotherapeutics Ⅲ
- Subject No 37136Class No 03
- 5Year ( 3Credit , 3Hour) Mon 4~4 , Tue 6~6
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 01
- 5Year ( 1.5Credit , 3Hour) Wed 5~6 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 02
- 5Year ( 1.5Credit , 3Hour) Mon 5~6 (PHM-A206)
- Major Requisite
-
Pharmaceutical Experiment Laboratory VI
- Subject No 37138Class No 03
- 5Year ( 1.5Credit , 3Hour) Thu 5~6 (PHM-A206)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 01
- 6Year ( 4Credit
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 02
- 6Year ( 4Credit , 0Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 03
- 6Year ( 4Credit , 0Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 04
- 6Year ( 4Credit , 0Hour)
- Major Requisite
-
Hospital Pharmacy Practice I
- Subject No 37150Class No 05
- 6Year ( 4Credit , 0Hour)
- Major Requisite
-
Clinical Data Analysis and Applications
- Subject No G18092Class No 01
- Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
-
Academic Background
University of Maryland, Baltimore Pharm.D. (pharmacy)